Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Open-Label Study of the Effect of 15% Eflornithine Hydrochloride Cream on Facial Hair of Men of African-American Descent With Pseudofolliculitis Barbae: A Laser Scanning Confocal Microscopy and Video Imaging Study

NCT00176995 is registered in ClinicalTrials.gov with Hordinsky, Maria K., MD as lead sponsor.

NCT NCT00176995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00176995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Open-Label Study of the Effect of 15% Eflornithine Hydrochloride Cream on Facial Hair of Men of African-American Descent With Pseudofolliculitis Barbae: A Laser Scanning Confocal Microscopy and Video Imaging Study
Lead sponsor
Hordinsky, Maria K., MD
Phase
Phase 2
Overall status
Completed
Start date
March 31, 1999
Completion date
October 31, 2000
Enrollment
15
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pseudofolliculitis barbae